Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2018-09-12
XBITXbiotech Inc.McKenzie W ThorpeDir, 10%S - Sale$3.07-49,5843,912,734-1%-$152,095
M
2018-09-13
VTLVital Therapies IncSatter Muneer ADir, 10%S - Sale$0.36-11,382,2770-100%-$4,145,637
2018-09-13
VTLVital Therapies IncHasnain FaheemDirS - Sale$0.44-177,4438,000-96%-$77,679
2018-09-13
VTLVital Therapies IncBienaime Jean JacquesDirS - Sale$0.47-20,00045,119-31%-$9,400
D
2018-09-13
BMRNBiomarin Pharmaceutical IncMeier Richard ADirS - Sale+OE$99.24-3,00081,610-4%-$297,722
DM
2018-09-11
PKTXProtokinetix, Inc.Smith Clarence EdwardPres, CEO, 10%P - Purchase$0.12+150,00063,617,3020%+$17,988
2018-09-13
BMRNBiomarin Pharmaceutical IncDavis George EricEVP, GCS - Sale$99.57-12,00074,950-14%-$1,194,840
2018-09-14
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickEVP, US CommercialS - Sale$165.20-20025,372-1%-$33,040
D
2018-09-14
APLSApellis Pharmaceuticals, Inc.Watson David O.GCS - Sale+OE$18.78-15,77627,042-37%-$296,336
M
2018-09-13
ATHXAthersys, Inc / NewHarrington John JExec Vice Pres, CSOS - Sale$1.91-15,000667,770-2%-$28,707
M
2018-09-13
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$1.20+210,0007,386,163+3%+$252,354
M
2018-09-13
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$1.20+210,0007,386,163+3%+$252,354
M
2018-09-13
NERVMinerva Neurosciences, Inc.Doyle William FDirP - Purchase$10.50+2,20010,211+27%+$23,100
2018-09-13
BHCBausch Health Companies Inc.De Schutter Richard UDirP - Purchase$23.96+125,000269,727+86%+$2,995,000
2018-09-14
BHCBausch Health Companies Inc.Herendeen PaulEVP, CFOP - Purchase$22.61+10,000226,866+5%+$226,100
2018-09-14
BHCBausch Health Companies Inc.Papa Joseph CCOB, CEOP - Purchase$22.32+30,000687,077+5%+$669,600
2018-09-13
CTLTCatalent, Inc.Morel Donald E JrDirP - Purchase$43.00+10,00036,958+37%+$430,000
2018-09-13
FOLDAmicus Therapeutics IncPerceptive Advisors LLC10%P - Purchase$11.74+100,00020,624,4240%+$1,174,000
D
2018-09-12
PAHCPhibro Animal Health CorpBfi Co., LLC10%S - Sale+OE$45.04-52059,480-1%-$23,421
D
2018-09-12
PAHCPhibro Animal Health CorpBendheim Daniel MEVP, Corporate StrategyS - Sale+OE$44.30-2,5000-100%-$110,750
D
2018-09-12
PAHCPhibro Animal Health CorpBendheim JackPres, CEO, 10%S - Sale+OE$45.04-52059,480-1%-$23,421
DM
2018-09-12
TXMDTherapeuticsmd, Inc.Bernick BrianDirS - Sale+OE$6.30-182,8006,802,371-3%-$1,151,640
2018-09-13
ADROAduro Biotech, Inc.Templeman BlaineEVP, GCS - Sale$6.50-6,056141,381-4%-$39,360
2018-09-13
ADROAduro Biotech, Inc.Van Elsas AndreaChief Scientific OfficerS - Sale$6.50-9,754264,286-4%-$63,394
2018-09-13
ADROAduro Biotech, Inc.Lew JenniferCFOS - Sale$6.50-5,623136,190-4%-$36,546
2018-09-13
ADROAduro Biotech, Inc.Sacks NatalieChief Medical OfficerS - Sale$6.50-3,028173,720-2%-$19,680
2018-09-13
ADROAduro Biotech, Inc.Isaacs Stephen TPres, CEOS - Sale$6.50-24,143341,785-7%-$156,913
2018-09-14
INNTInnovate Biopharmaceuticals, Inc.Prior Christopher P.CEOP - Purchase$5.82+2002,009+11%+$1,164
DM
2018-09-12
LOXOLoxo Oncology, Inc.Burstein JenniferSVP of FinanceS - Sale+OE$166.96-2,5000-100%-$417,392
DM
2018-09-12
LOXOLoxo Oncology, Inc.Bilenker Joshua H.Pres, CEOS - Sale+OE$166.20-20,000165,407-11%-$3,323,965
DM
2018-09-12
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerS - Sale+OE$166.32-10,00013,700-42%-$1,663,179
DM
2018-09-12
BDSIBiodelivery Sciences International IncOdonnell Francis E JrDirS - Sale+OE$2.84-151,039538,187-22%-$428,284
D
2018-09-12
RSPIRespirerx Pharmaceuticals Inc.Lippa ArnoldExec COB, CSOP - Purchase$0.00+47,6200-100%+$0
D
2018-09-13
FGENFibrogen IncCotroneo PatSVP, Finance, CFOS - Sale+OE$59.50-2,318228,604-1%-$137,921
2018-09-12
TBPHTheravance Biopharma, Inc.Worboys Philip DSVP, Translational ScienceS - Sale$28.50-6,393166,753-4%-$182,201
2018-09-12
VTLVital Therapies IncCohen CherylDirS - Sale$0.55-3,5000-100%-$1,925
M
2018-09-12
ZYMEZymeworks Inc.Lilly Eli & Co10%S - Sale$14.49-30,9593,873,418-1%-$448,463
M
2018-09-10
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.04+7,00025,916,7980%+$273
2018-09-11
AMARAmarillo Biosciences IncChen Stephen TPres,COB, CEO, 10%P - Purchase$0.33+1,0005,918,4970%+$330
2018-09-12
FOLDAmicus Therapeutics IncPerceptive Advisors LLC10%P - Purchase$12.00+500,00020,524,424+2%+$6,001,500
D
2018-09-13
GERNGeron CorpSpiegel Robert J.DirS - Sale+OE$6.85-175,00065,576-73%-$1,198,750
M
2018-09-11
NVUSNovus Therapeutics, Inc.Turkel Catherine C.PresP - Purchase$4.78+33,68079,004+74%+$161,147
2018-09-12
INNTInnovate Biopharmaceuticals, Inc.Prior Christopher P.CEOP - Purchase$6.13+5001,809+38%+$3,065
D
2018-09-11
ADXSAdvaxis, Inc.Appel RoniDirP - Purchase$1.20+33,333157,143+27%+$40,000
2018-09-11
PFNXPfenex Inc.Schimmelpennink Evert B.See RemarksP - Purchase$5.04+10,00026,658+60%+$50,385
2018-09-11
PFNXPfenex Inc.Schneider Phillip MDirP - Purchase$4.99+11,00011,000New+$54,890
M
2018-09-11
AGIOAgios Pharmaceuticals IncMaraganore JohnDirS - Sale$72.23-27,71722,047-56%-$2,002,110
M
2018-09-10
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$1.18+475,0007,176,163+7%+$558,393
M
2018-09-10
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$1.18+475,0007,176,163+7%+$558,393
DM
2018-09-10
TXMDTherapeuticsmd, Inc.Milligan John C.K. IVPres, SecretaryS - Sale+OE$6.10-250,0005,464,606-4%-$1,523,875
M
2018-09-10
RIGLRigel Pharmaceuticals IncMayer Eldon C. IIIEVP, Chief Commercial OfficerP - Purchase$3.26+100,000215,000+87%+$325,550
2018-09-10
KALVKalvista Pharmaceuticals, Inc.Oronsky Arnold LDirP - Purchase$17.00+58,824388,766+18%+$1,000,008
2018-09-10
KALVKalvista Pharmaceuticals, Inc.Cha AlbertDirP - Purchase$17.00+1,058,8241,359,149+353%+$18,000,008
2018-09-10
FGENFibrogen IncCotroneo PatSVP, Finance, CFOS - Sale$57.35-1,011220,4220%-$57,981
D
2018-09-10
FGENFibrogen IncRoutti JormaDirS - Sale+OE$57.31-6,000131,540-4%-$343,837
M
2018-09-10
ZYMEZymeworks Inc.Lilly Eli & Co10%S - Sale$14.75-15,7773,904,3770%-$232,669
2018-09-12
HRTXHeron Therapeutics, Inc. /de/Tang Kevin CDir, 10%S - Sale$35.75-2,695,0005,851,503-32%-$96,346,250
M
2018-09-10
BSTCBiospecifics Technologies CorpWegman Mark NDirS - Sale$57.52-6,50065,272-9%-$373,861
M
2018-09-10
NERVMinerva Neurosciences, Inc.Doyle William FDirP - Purchase$9.80+8,0118,011New+$78,507
D
2018-09-10
KPTIKaryopharm Therapeutics Inc.Primiano Christopher BrettEVP, CBO, GC, SecretaryS - Sale+OE$18.90-10,0002,881-78%-$189,046
M
2018-09-07
XBITXbiotech Inc.McKenzie W ThorpeDir, 10%S - Sale$3.31-29,6033,962,318-1%-$98,097
2018-09-10
IMGNImmunogen IncBerkenblit AnnaVP, Chief Medical OfficerS - Sale$9.46-5,851138,620-4%-$55,350
2018-09-07
MCRBSeres Therapeutics, Inc.Pomerantz RogerPres, CEOS - Sale$9.00-1,810213,976-1%-$16,291
D
2018-09-07
CORTCorcept Therapeutics IncFishman Robert SChief Medical OfficerS - Sale+OE$14.57-8,0000-100%-$116,533
D
2018-09-10
TEVATeva Pharmaceutical Industries LtdDaniell RichardEVP, European CommercialS - Sale+OE$21.25-6960-100%-$14,790
M
2018-09-07
GALTGalectin Therapeutics IncOmenn Gilbert SDirS - Sale$6.02-19,37048,191-29%-$116,585
2018-09-07
JNJJohnson & JohnsonKapusta Ronald AController, CAOS - Sale$137.18-7,89926,485-23%-$1,083,607
2018-09-07
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.04+15,60025,909,7980%+$599
DM
2018-09-06
TXMDTherapeuticsmd, Inc.Finizio Robert GCEO, 10%S - Sale+OE$6.24-184,00020,393,559-1%-$1,147,240
D
2018-09-06
ARWRArrowhead Pharmaceuticals, Inc.Myszkowski Kenneth AllenCFOS - Sale+OE$19.34-45,000310,815-13%-$870,200
2018-09-07
INNTInnovate Biopharmaceuticals, Inc.Laumas SandeepExec COBP - Purchase$6.10+500760,3730%+$3,050
D
2018-09-06
VTVTVtv Therapeutics Inc.Perelman Ronald O10%P - Purchase$1.33+1,879,6996,778,470+38%+$2,500,000
2018-09-06
REGNRegeneron Pharmaceuticals IncSanofi10%S - Sale$406.68-104,55223,654,3840%-$42,519,249
D
2018-09-07
KPTIKaryopharm Therapeutics Inc.Kauffman MichaelCEOS - Sale+OE$19.31-12,5001,320,271-1%-$241,384
D
2018-09-07
KPTIKaryopharm Therapeutics Inc.Shacham SharonPres, CSOS - Sale+OE$19.31-12,5001,320,271-1%-$241,384
2018-09-10
UTHRUnited Therapeutics CorpCausey ChristopherDirS - Sale$119.00-8101,555-34%-$96,390
2018-09-06
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.04+1,00025,894,1980%+$40
M
2018-09-05
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.04+38,00025,893,1980%+$1,685
2018-08-23
AMARAmarillo Biosciences IncChen Stephen TPres,COB, CEO, 10%P - Purchase$0.35+1,0005,917,4970%+$350
2018-09-07
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$106.76-180,000119,790,8040%-$19,217,055
2018-09-06
SCYXScynexis IncAngulo Gonzalez DavidChief Medical OfficerP - Purchase$1.27+7,000108,790+7%+$8,890
2018-09-07
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$5.57+10,000191,757,3260%+$55,705
2018-09-07
OPKOpko Health, Inc.Fishel Robert ScottDirP - Purchase$4.63+10,0004,070,7280%+$46,300
2018-09-05
NVUSNovus Therapeutics, Inc.Turkel Catherine C.PresP - Purchase$3.97+80545,324+2%+$3,193
DM
2018-09-06
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$57.51-39,6362,913,326-1%-$2,279,500
M
2018-09-05
KPTIKaryopharm Therapeutics Inc.Chione Ltd10%S - Sale$21.05-164,8007,631,267-2%-$3,468,730
2018-09-05
ICPTIntercept Pharmaceuticals, Inc.Shapiro DavidChief Medical OfficerS - Sale$111.43-4,91742,196-10%-$547,891
M
2018-09-05
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$0.86+160,0006,701,163+2%+$138,162
M
2018-09-05
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$0.86+160,0006,701,163+2%+$138,162
2018-09-07
BSTCBiospecifics Technologies CorpGitman PaulDirS - Sale$57.64-1,00020,000-5%-$57,637
D
2018-08-30
STDYSteadymed Ltd.Orbimed Advisors LLC10%S - Sale+OE$4.46-4,246,1960-100%-$18,938,034
M
2018-09-05
ASMBAssembly Biosciences, Inc.Lopatin Uri AChief Med. Officer, VP Res. DeS - Sale$40.09-15,540618,611-2%-$622,989
D
2018-09-06
JAZZJazz Pharmaceuticals PlcEnright Patrick GDirS - Sale+OE$168.76-10,13016,469-38%-$1,709,565
D
2018-09-06
ATNXAthenex, Inc.Wu JinnDirP - Purchase$16.09+2,500266,708+1%+$40,220
D
2018-09-05
AGIOAgios Pharmaceuticals IncAlenson CarmanPrincipal Accounting OfficerS - Sale+OE$83.00-312152-67%-$25,896
D
2018-09-06
UTHRUnited Therapeutics CorpCausey ChristopherDirS - Sale+OE$118.00-8102,365-26%-$95,580
D
2018-09-05
AGIOAgios Pharmaceuticals IncBiller ScottChief Scientific OfficerS - Sale+OE$83.07-3,00057,196-5%-$249,215
2018-09-06
CYTKCytokinetics IncMalik Fady IbrahamEVP Research, DevelopmentS - Sale$8.00-1,50091,567-2%-$12,000
2018-09-05
CYTKCytokinetics IncBlum Robert IPres, CEOS - Sale$7.94-4,000168,188-2%-$31,769
2018-09-05
SYBXSynlogic, Inc.Miller Paul FrancisChief Scientific OfficerS - Sale$12.55-3,00063,135-5%-$37,635
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top